532 POSTER A chimerized anti-CD4 monoclonal antibody for the treatment of T cell lymphomas acts through activation of membrane acid sphingomyelinase leading to increased ceramide release and CD4/ZAP-70 protein redistribution in membrane rafts
M. Chentouf, M. Rigo, A. Pèlegrin, T. ChardèsVolume:
6
Year:
2008
Language:
english
DOI:
10.1016/s1359-6349(08)72466-2
File:
PDF, 72 KB
english, 2008